Clinical Trials in North Carolina

Showing 16461-16480 of 19,716 trials

Depression Screening in Patients Undergoing Radiation Therapy For Cancer

NCT00951184

RATIONALE: Gathering information about depression in patients with cancer may help doctors learn more about the disease and plan the best treatment. PURPOSE: This clinical trial is studying depression screening in patients undergoing radiation therapy for cancer.

DepressionUnspecified Adult Solid Tumor, Protocol Specific

Radiation Therapy Oncology Group463 participantsStarted May 2009

Alton, Illinois, United States • Grand Rapids, Michigan, United States • Grand Rapids, Michigan, United States +13 more locations

TERMINATEDPhase 241 miles

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

NCT00068770

RATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for their growth. It is not yet known whether the effectiveness of celecoxib in treating glioblastoma multiforme is decreased in patients who are receiving anticonvulsant drugs and undergoing radiation therapy. PURPOSE: Phase II trial to study the effectiveness of celecoxib in treating patients who are receiving anticonvulsant drugs and undergoing radiation therapy for newly diagnosed glioblastoma multiforme.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins35 participantsStarted Oct 2003

Tampa, Florida, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +4 more locations

Depression Screening in Patients Undergoing Radiation Therapy For Cancer

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Find Trials by Condition in North Carolina

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Effects of HQK-1001 in Patients With Sickle Cell Disease

Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Dialysis Clinical Outcomes Revisited (DCOR) Trial

The BRILLIANT Study

Phase IIIB Subcutaneous Abatacept Monotherapy Study

Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

TeleQuit Smoking Cessation Program

A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme